Payers, providers, and regulators are increasingly looking at new types of data and evidence when evaluating price and value – especially for innovative products. Understanding how these stakeholders define value, which evidence data matters, and where your portfolio may face risk worldwide is an essential element in any market access strategy to protect and expand commercial success. Furthermore, companies need to understand how their product can differentiate itself in the market even after the patent has expired. We can help you from the early stages of concept and strategy development to late commercialization and life cycle management stages.
A successful value proposition for all life sciences products, including drugs, medical devices, and diagnostics, must be accompanied by product value evidence. We work with clients in all development and commercialization phases to identify market access challenges, opportunities, and evidence-generation activities to support successful outcomes. Our capabilities include:
Analyze the competitive landscape, and identify evidence requirements
Evaluate product attributes and opportunities for evidence generation, the strength of supporting evidence, and opportunities to fill gaps
Develop a detailed roadmap for evidence generation and communication of product value
Assess of clinical and economic value versus alternatives in early phases, using modeling and simulation
Develop value proposition and key-value messages, supported by evidence and research to gain an understanding of stakeholder needs
Identify trends across segments and geographies
HDI Group has developed unique methodologies that enable biopharmaceutical organizations to make robust pricing across therapeutic areas, geographies, channels, and product types. Our capabilities include: Pricing Strategies, Contracting and Tendered Business Management, Competitive Response Strategies, Copay and Other Patient Support Solutions. Notably, we can help you:
Evaluate pricing and market access options for pipeline products
Create pricing models to support and evaluate key decisions
Develop integrated pricing strategies for launch products
Design and implement innovative pricing, contracting, and reimbursement arrangements
Review and optimize the performance of contracting and global tendered business
Conduct competitive-response simulations
Design and deliver high return on investment copay support solutions
Assess and develop integrated care and other novel care delivery models
Develop models that forecast revenue, estimate product and portfolio value and return on investment, and that simulate the clinical and economic value
Partner with clients early in the product life cycle to establish the evidence strategy to support a winning value proposition for stakeholders globally
Develop best-practice pricing and bid tools and processes for contracting and tender business management
Conduct advanced payer analytics, including segmentation, performance tracking, and payer impact modeling
Develop strategic responses to branded, biosimilar, and generic competition
To effectively help our clients communicate the clinical, economic and humanistic value of their products to key stakeholders, we provide the following services:
Support reimbursement submissions and health technology assessments across global markets
Develop dossiers for the assessment of new technologies, such as diagnostics, including dossiers that are designed to meet policy requirements
Synthesize available evidence into the dossiers required by health technology appraisal bodies around the world and develop a range of focused communication tools
Develop evidence packages for hospital-based products, including pharmaceuticals, diagnostics, and medical devices
Create tools for account managers and medical science liaisons to enhance communication tools for Field-Based Teams
Communicate to stakeholders the impact innovation can have on patients, institutions, or health care systems.
Optimize price, access, and reimbursement, including the use of innovative contracting approaches with payers worldwide
Economic evaluations play a key role in informing strategic, organizational, and funding decisions. We can help you demonstrate the value of medicine through evidence-based health economic evaluation and real-world outcomes for optimal pricing, reimbursement, and coverage potential. Our capabilities include:
Develop models of complex consumer decision making
Develop, validate, adapt and assess decision-analytic models
Develop cost-effectiveness, cost-utility analysis
Develop budget impact analysis/ forecast
Develop health economic analysis of sponsors’ product portfolio
Detect the potential for health economic value propositions
Perform analysis of sponsors’ health economics strategies and plannin
Perform feasibility studies, run evidence appraisal and synthesis
Offer insights into the quality of life, disability-adjusted life years, and other aspects that move beyond the clinical outcomes
Perform instrument validation, develop outcome measures and clinical scales
Perform decision trees, perform retrospective database analysis
Perform microsimulation models
Launch strategy requires constant attention and a real-time market pulse to optimize customer engagement, identify new competitive hurdles, manage risk, and invest with assurance. Our team is ready to help with:
Launch planning
Tracking and management
Brand strategy and development
Global pricing and market access strategy
Disease awareness, medical advocacy strategy, and communications
Forecast demand
Track competitive landscape changes
Deliver timely market insights to help differentiate your brand
Quantify multi-indication product use
Evaluate the effectiveness of marketing activities such as medical visits or marketing campaigns
Personalize marketing campaigns using insights from neuroscience and behavioral science
Evaluate the brand value and positioning on the market and design a comprehensive communication strategy for the company, portfolio, and brand strategy
Understand the context of disease and patient populations such as unmet population needs, biomarkers, and genetic characteristics
Understand market dynamics
The Engine Behind The Know-how
HDI Group integrates unparalleled data, transformative technology, advanced analytics, and domain expertise and puts it seamlessly within reach.
Multiple data types from the world’s most reliable sources, constantly gathered, updated, and usably integrated.
Domain experts worldwide can support you, from sales analytics and forecasting to competitive intelligence, data cleaning, and coding.
Machine learning that projects future-facing, data-based insights.
To know more about our projects and training Contact Us.
